Literature DB >> 29654218

p53: emerging roles in stem cells, development and beyond.

Abhinav K Jain1, Michelle Craig Barton1.   

Abstract

Most human cancers harbor mutations in the gene encoding p53. As a result, research on p53 in the past few decades has focused primarily on its role as a tumor suppressor. One consequence of this focus is that the functions of p53 in development have largely been ignored. However, recent advances, such as the genomic profiling of embryonic stem cells, have uncovered the significance and mechanisms of p53 functions in mammalian cell differentiation and development. As we review here, these recent findings reveal roles that complement the well-established roles for p53 in tumor suppression.
© 2018. Published by The Company of Biologists Ltd.

Entities:  

Keywords:  Development; Differentiation; Embryonic stem cells; lncRNA; p53

Mesh:

Substances:

Year:  2018        PMID: 29654218     DOI: 10.1242/dev.158360

Source DB:  PubMed          Journal:  Development        ISSN: 0950-1991            Impact factor:   6.868


  34 in total

1.  The Molecular Chaperone Heat Shock Protein 70 Controls Liver Cancer Initiation and Progression by Regulating Adaptive DNA Damage and Mitogen-Activated Protein Kinase/Extracellular Signal-Regulated Kinase Signaling Pathways.

Authors:  Wonkyoung Cho; Xiongjie Jin; Junfeng Pang; Yan Wang; Nahid F Mivechi; Demetrius Moskophidis
Journal:  Mol Cell Biol       Date:  2019-04-16       Impact factor: 4.272

Review 2.  p53 and Cell Fate: Sensitizing Head and Neck Cancer Stem Cells to Chemotherapy.

Authors:  Christie Rodriguez-Ramirez; Jacques E Nör
Journal:  Crit Rev Oncog       Date:  2018

3.  Emerging roles of long non-coding RNAs in the p53 network.

Authors:  Abhinav K Jain
Journal:  RNA Biol       Date:  2020-06-04       Impact factor: 4.652

Review 4.  A connection in life and death: The BCL-2 family coordinates mitochondrial network dynamics and stem cell fate.

Authors:  Megan L Rasmussen; Vivian Gama
Journal:  Int Rev Cell Mol Biol       Date:  2020-01-27       Impact factor: 6.813

Review 5.  Micronutrient imbalance and common phenotypes in neural tube defects.

Authors:  Anneke Dixie Kakebeen; Lee Niswander
Journal:  Genesis       Date:  2021-10-19       Impact factor: 2.487

6.  Post-transcriptional regulation by the exosome complex is required for cell survival and forebrain development via repression of P53 signaling.

Authors:  Pauline Antonie Ulmke; Yuanbin Xie; Godwin Sokpor; Linh Pham; Orr Shomroni; Tea Berulava; Joachim Rosenbusch; Uttiya Basu; Andre Fischer; Huu Phuc Nguyen; Jochen F Staiger; Tran Tuoc
Journal:  Development       Date:  2021-02-08       Impact factor: 6.868

7.  Wnt/ß-catenin-mediated p53 suppression is indispensable for osteogenesis of mesenchymal progenitor cells.

Authors:  Xin Zhou; Allyson Beilter; Zhaohui Xu; Ruli Gao; Shunbin Xiong; Adriana Paulucci-Holthauzen; Guillermina Lozano; Benoit de Crombrugghe; Richard Gorlick
Journal:  Cell Death Dis       Date:  2021-05-21       Impact factor: 8.469

8.  CENP-A overexpression promotes distinct fates in human cells, depending on p53 status.

Authors:  Daniel Jeffery; Alberto Gatto; Katrina Podsypanina; Charlène Renaud-Pageot; Rebeca Ponce Landete; Lorraine Bonneville; Marie Dumont; Daniele Fachinetti; Geneviève Almouzni
Journal:  Commun Biol       Date:  2021-03-26

9.  Loss of tumor protein 53 protects against alcohol-induced facial malformations in mice and zebrafish.

Authors:  Eric W Fish; Scott K Tucker; Rachel L Peterson; Johann K Eberhart; Scott E Parnell
Journal:  Alcohol Clin Exp Res       Date:  2021-09-28       Impact factor: 3.928

10.  RNA sequencing of long-term label-retaining colon cancer stem cells identifies novel regulators of quiescence.

Authors:  Joseph L Regan; Dirk Schumacher; Stephanie Staudte; Andreas Steffen; Ralf Lesche; Joern Toedling; Thibaud Jourdan; Johannes Haybaeck; Dominik Mumberg; David Henderson; Balázs Győrffy; Christian R A Regenbrecht; Ulrich Keilholz; Reinhold Schäfer; Martin Lange
Journal:  iScience       Date:  2021-05-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.